Vor Biopharma Inc.

VOR Healthcare Biotechnology

18.03 1.31 −6.77%
Market cap
$1.1B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Sep '23 Jun '23 Mar '23 Dec '22 Older periods
Cash and Short Term Investments
160.10 186.90 210.20 230.25

+8 more quarters

Other current assets
4.34 4.49 6.70 6.71
Total current assets
164.44 191.39 216.90 236.95
Total Assets
— — — —
Accounts Payable
1.31 1.65 3.22 1.77
Current Part of Debt
3.74 3.69 3.71 3.27
Other current liabilities
10.34 7.38 5.65 8.08
Total current liabilities
15.39 12.72 12.58 13.12
Total liabilities
48.24 46.54 47.32 48.76
Common Stock (Net)
0.01 0.01 0.01 0.01
Retained Earnings
(313.82) (280.63) (250.65) (222.22)
Common Equity (Total)
174.78 204.45 230.22 250.61
Shareholders Equity (Total)
174.78 204.45 230.22 250.61
Net Debt
(123.50) (149.39) (171.75) (191.33)
Total Debt
36.60 37.51 38.45 38.91
Other line items
Property, Plant, Equpment (Net)
52.09 53.91 55.43 57.08
Long-Term Investments
2.41 2.41 2.41 2.41
Long-term assets (Other)
4.09 3.27 2.79 2.93
Long Term Debt (Total)
32.85 33.82 34.74 35.64

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 5 Oct 2026